Why is Gland Pharma falling/rising?

As of 23-Sep, Gland Pharma Ltd's stock price is currently at 2,013.90, reflecting a decrease of 3.9 points or 0.19%. The stock has been experiencing a decline, having fallen for the last two days with a total return of -0.39% during this period. Despite this recent downturn, Gland Pharma has shown positive performance over the past month, with a return of 3.24%, and a year-to-date increase of 12.60%. The company has a low debt-to-equity ratio, which is favorable, and it reported strong financial results in June, including record net sales and profit before tax. However, there has been a notable decrease in investor participation, with delivery volume dropping by 12.03% against the five-day average, which may contribute to the stock's current decline. In the broader market context, Gland Pharma's recent performance is slightly better than the benchmark Sensex, which has seen a decline of 0.34% over the past week. While the stock has outperformed the market over the past year with a return of 9.27% compared to the Sensex's -3.33%, its three-year performance has lagged significantly behind the benchmark, which has risen by 41.31%. This disparity may reflect broader market trends affecting investor sentiment. Despite high institutional holdings at 40.24%, which typically indicates confidence in the company's fundamentals, the recent drop in trading volume and consecutive price falls suggest cautious sentiment among investors.